News 15. Mai 2024 Allegria Therapeutics raises 3.5 million dollars in seed financing round Allegria Therapeutics has received seed funding of 3.5 million dollars from the founding investor Forty51 Ventures. The biotech startup is develo...
News 13. Mai 2024 Canton of Zug funds institute for blockchain research The canton of Zug is contributing to the costs of setting up an institute for blockchain research. The project of the University of Lucerne and L...
News 10. Mai 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Aktuell 15. Mai 2024 Allegria Therapeutics nimmt 3,5 Millionen Dollar in Seed-Runde ein Allegria Therapeutics hat eine Seed-Finanzierung von 3,5 Millionen Dollar durch den Gründungsinvestor Forty51 Ventures erhalten. Das Biotech-Star...
News 30. Apr. 2024 Johnson & Johnson opens Innovation Hub in Allschwil Johnson & Johnson has opened its first J&J Innovation Hub on the European mainland at the Switzerland Innovation Park Basel Area. This represents...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Aktuell 30. Apr. 2024 Johnson & Johnson eröffnet Innovation Hub in Allschwil Johnson & Johnson hat im Switzerland Innovation Park Basel Area den ersten J&J Innovation Hub auf dem europäischen Festland eröffnet. Es stellt e...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Aktuell 10. Mai 2024 BioVersys erweitert Serie-C-Runde auf 44,9 Millionen Franken BioVersys verstärkt die Zusammenarbeit mit GSK, um die Entwicklung von Alpibectir zur Behandlung von Tuberkulose zu beschleunigen. GSK beteiligt ...
News 09. Apr. 2024 DESI project unveils groundbreaking 3D universe map with EPFL’s aid EPFL astrophysicists have contributed to creating the most detailed 3D map of the universe, tracing expansion over 11 billion years.
News 03. Apr. 2024 Nouscom receives additional funding for cancer vaccines Nouscom has received an investment totalling 7 million euros from the Italian venture capital firm Angelini Ventures. The Basel-based biotech com...
News 07. Mai 2024 UZH researching innovative cancer therapy Researchers from the University of Zurich (UZH) are in the process of developing new cancer therapeutics. Known as radiotheranostics, these drugs...
Aktuell 13. Mai 2024 Kanton Zug fördert Institut für Blockchain-Forschung Der Kanton Zug beteiligt sich an den Aufbaukosten eines Instituts für Blockchain-Forschung. Für das Projekt der Universität Luzern und der Hochsc...
Actualités 17. Apr. 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
News 30. Apr. 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
News 01. März 2024 EthereumZuri.ch 2024 conference to focus on innovation The second EthereumZuri.ch conference will celebrate Ethereum's 10th anniversary. Since it was founded, the Greater Zurich Area has established i...
Aktuell 07. Mai 2024 UZH forscht an neuer Krebstherapie Forschende der Universität Zürich (UZH) entwickeln neue Krebstherapeutika. Die sogenannten Radiotheranostika sollen Tumore gleichzeitig lokalisie...